Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessing Longitudinal Performance Trends in Lung Cancer Surgery: Insights from the French National Hospital Database (2020-2024)

  • By

  • Alain Bernard

  • Jonathan Cottenet

  • Pascale Tubert-Bitter

  • Catherine Quantin

  • June 22, 2026

Share

  • 1

    This study analyzes lung cancer surgery performance across 148 French hospitals from 2020 to 2024, involving 56,299 patients.

  • 2

    Severe complications occurred in 15%–40% of cases, with 2%–5% mortality, highlighting significant interhospital variability.

  • 3

    Medium-volume hospitals showed optimal improvement trajectories with a 45% reduction in risk-adjusted complications.

  • 4

    Some low-volume hospitals experienced a catastrophic 843% increase in complication rates, while a subgroup of high-volume hospitals also deteriorated.

  • 5

    The study suggests that surgical volume alone does not guarantee quality, emphasizing the importance of organizational factors and continuous feedback.

Original Source(s)

Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024

  • by Alain Bernard, Jonathan Cottenet, Pascale Tubert-Bitter, Catherine Quantin

  • June 22, 2026

Related Content

Diagnostic performance of a single breath-hold lung MRI scan with AI-powered compressed sensing for nodule detection in comparison to photon counting detector-CT

Generalizability and Fairness in Deploying AI for Lung Cancer Biomarker Prediction

Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening